Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Axsome Thera (NQ: AXSM ) 86.05 +1.20 (+1.41%) Streaming Delayed Price Updated: 4:00 PM EDT, Jul 22, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 613,308 Open 86.42 Bid (Size) 84.40 (1) Ask (Size) 86.75 (4) Prev. Close 84.85 Today's Range 83.88 - 86.79 52wk Range 55.02 - 98.40 Shares Outstanding 47,190,970 Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Axsome Therapeutics' CNS Portfolio Poised for Major Growth - Analyst Predicts Strong Future Today 15:06 EDT Needham initiated coverage on Axsome Therapeutics, highlighting its diverse CNS portfolio. The analyst predicts an 8-10x risk-adjusted topline growth in five years, driven by marketed drugs Auvelity... Via Benzinga Decoding 9 Analyst Evaluations For Axsome Therapeutics July 18, 2024 Via Benzinga Performance YTD +11.67% +11.67% 1 Month +9.62% +9.62% 3 Month +21.03% +21.03% 6 Month -5.36% -5.36% 1 Year +17.07% +17.07% More News Read More Bull Market and Beyond: 2 Stocks Just Waiting to Soar July 15, 2024 Via The Motley Fool Axsome Therapeutics to Report Second Quarter 2024 Financial Results on August 5 July 11, 2024 From Axsome Therapeutics, Inc. Via GlobeNewswire The 3 Best Biotech Stocks to Buy in July 2024 July 05, 2024 Via InvestorPlace Should You Buy This Sinking Stock on the Dip? June 27, 2024 Via The Motley Fool 15 Analysts Assess Axsome Therapeutics: What You Need To Know June 05, 2024 Via Benzinga 3 Undervalued Biotech Gems With 200%+ Analyst Price Targets July 04, 2024 Via InvestorPlace Why Axsome Therapeutics Stock Is Sinking Today June 11, 2024 Via The Motley Fool Axsome Therapeutics Settles Sunosi® (solriamfetol) Patent Litigation with Unichem Laboratories June 05, 2024 From Axsome Therapeutics, Inc. Via GlobeNewswire Axsome Therapeutics Joins the American Migraine Foundation to Highlight Unmet Treatment Needs During Migraine & Headache Awareness Month June 04, 2024 From Axsome Therapeutics, Inc. Via GlobeNewswire Axsome Therapeutics Supports Alzheimer’s & Brain Awareness Month June 03, 2024 From Axsome Therapeutics, Inc. Via GlobeNewswire Axsome Therapeutics to Participate in Upcoming Investor Conferences May 30, 2024 From Axsome Therapeutics, Inc. Via GlobeNewswire Axsome Therapeutics Highlights Data on Solriamfetol Demonstrating Improvement in Cognitive Function in Patients with Obstructive Sleep Apnea or Narcolepsy at SLEEP 2024 May 29, 2024 From Axsome Therapeutics, Inc. Via GlobeNewswire Axsome Therapeutics Presents Data from Multiple Programs at the 2024 American Society of Clinical Psychopharmacology Annual (ASCP) Meeting May 28, 2024 From Axsome Therapeutics, Inc. Via GlobeNewswire Hello Group And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session May 28, 2024 Via Benzinga 3 Monster Stocks in the Making You Can Buy Right Now May 18, 2024 Via The Motley Fool The 3 Most Undervalued Biotech Stocks to Buy in May 2024 May 11, 2024 Via InvestorPlace Prediction: These 2 Growth Stocks Could Triple By 2030 May 11, 2024 Via The Motley Fool Axsome Therapeutics to Present at Upcoming Investor Conferences May 08, 2024 From Axsome Therapeutics, Inc. Via GlobeNewswire Axsome Therapeutics (AXSM) Q1 2024 Earnings Call Transcript May 06, 2024 Via The Motley Fool Topics Earnings Exposures Financial AXSM Stock Earnings: Axsome Therapeutics Beats EPS, Beats Revenue for Q1 2024 May 06, 2024 Via InvestorPlace Axsome Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update May 06, 2024 From Axsome Therapeutics, Inc. Via GlobeNewswire Axsome Therapeutics Recognizes May as Mental Health Awareness Month May 01, 2024 From Axsome Therapeutics, Inc. Via GlobeNewswire AXSOME ALERT: Bragar Eagel & Squire, P.C. is Investigating Axsome Therapeutics, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm April 30, 2024 From Bragar Eagel & Squire Via GlobeNewswire Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.